Howy Jacobs appointed as Senior Editor of EMBO reports
EMBO reports publishes high-quality, short-format articles reporting scientific findings of broad interest and major biological significance in all areas of molecular biology. In addition, it features expert scientific reviews from leading researchers plus editorial content offering insight into issues affecting science and society. “We are extremely pleased to welcome Howy Jacobs as the new Senior Editor of EMBO reports,” said Hermann Bujard, EMBO Director. “Howy’s research creativity, his dedication to science that goes beyond his own field combined with his passion for science communication will serve him well in this role.” Howy Jacobs’ research focuses on mitochondrial genetics with a particular interest in the role of mitochondria in ageing and disease. He is known for his scientific rigor, his broad knowledge fed by his curiosity-driven approach to science and his commitment to the social relevance of research – all equally desirable attributes as Senior Editor of EMBO reports. Responding to his appointment, Howy Jacobs looks forward to “piloting the journal into its second decade and working with the editorial team to build upon the success of EMBO reports both within and beyond the molecular biology community.” He recognizes the work of his predecessor, Frank Gannon, who – within a decade - developed EMBO reports from concept stage to its current successful position. Howy Jacobs received his PhD in molecular biology from the University of Glasgow in 1981 and is currently at the University of Tampere in Finland, serving as Academy Professor and Professor of Molecular Biology at its Institute of Medical Technology. An EMBO Member since 2001, Jacobs was co-awarded the 2004 EU Descartes Prize for Research and is a member of the Finnish Academy of Science and Letters, the British Society of Cell Biology and both the Finnish and UK Genetics Societies. His research is currently supported by the Academy of Finland, the European Research Council, the Sigrid Juselius Foundation and the Medical Research Fund of Tampere University Hospital. A strong advocate for the advancement of European life science, Howy maintains an active profile coordinating research networks, organizing scientific meetings and participating in review panels. Most recently he was appointed to the ERC Starting Grants Review Panel. He is Director of the Academy of Finland Centre of Excellence in Research on Mitochondrial Disease and Ageing (FinMIT). Jacobs has published in EMBO reports, The EMBO Journal and EMBO Molecular Medicine (in press) as well as a broad range of life science journals. He also serves on a number of editorial boards and is often called upon as a reviewer for major journals, research agencies and foundations. Frank Gannon, in his former role as EMBO Executive Director (1994 – 2007), founded EMBO reports and served as its Senior Editor from its launch in 2000 until now. The realization of his vision has resulted in recognition of the unique role of the journal within the molecular biology community, combining groundbreaking science with incisive comment on how science and society shape one another in the twenty-first century. Over the years, Frank has taken a fearless approach to addressing topics relevant to scientists and to society in his editorials. “Frank Gannon has provided insight, energy and significant imagination throughout his tenure as Senior Editor,” said Hermann Bujard. “We thank him for his contribution that has shaped the content and direction of EMBO reports.” Readership levels of EMBO reports editorials will surely remain high as the baton passes from Gannon to Jacobs. Howy expects his self-admitted unconventional style to emerge in his monthly contributions, reflecting his “multifaceted personality, which somehow reconciles molecular biology with an enthusiasm for punk rock, viticulture, international politics and a curious obsession with all things Polar”. About EMBO The European Molecular Biology Organization (EMBO) promotes excellence in molecular life sciences in Europe by recognizing and fostering talented scientists. Since 1964, leading scientists are elected annually to become EMBO Members based on proven excellence in research. Members number more than 1300 today. Forty-eight scientists from the EMBO membership have received the Nobel Prize. Leading peer-reviewed journals – The EMBO Journal, EMBO reports and Molecular Systems Biology – span a broad spectrum of topics of molecular biology and reflect how science is shaping the world. A new journal, EMBO Molecular Medicine, publishes original research offering molecular insight into the cellular and systemic processes underlying human disease. EMBO funding, training and networking activities impact thousands of scientists every year, promoting collaboration in all areas of molecular biology – within its 27 member states, in Europe and neighbouring countries, and worldwide. For more information: www.embo.org
Countries
Austria, Belgium, Bulgaria, Cyprus, Czechia, Germany, Denmark, Estonia, Greece, Spain, Finland, France, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia, United Kingdom